Alembic Pharms

APR 13, 2026 · REGULATORY LABEL UPDATE

FDA supplemental approval: Lamotrigine (Labeling)

U.S. Food and Drug Administration

This is an FDA supplemental approval action for a labeling change to lamotrigine tablets; it documents a regulatory decision, not clinical trial evidence.